Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,849 | 203 | 95.1% |
| Education | $199.25 | 2 | 4.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $542.66 | 26 | $0 (2024) |
| GlaxoSmithKline, LLC. | $532.59 | 35 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $505.12 | 29 | $0 (2024) |
| Insmed, Inc. | $291.12 | 18 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $274.72 | 9 | $0 (2024) |
| United Therapeutics Corporation | $272.62 | 12 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $242.93 | 13 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $161.53 | 9 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $155.62 | 3 | $0 (2024) |
| GENZYME CORPORATION | $141.48 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,788 | 81 | AstraZeneca Pharmaceuticals LP ($261.90) |
| 2023 | $1,064 | 54 | Insmed, Inc. ($158.86) |
| 2022 | $884.65 | 51 | AstraZeneca Pharmaceuticals LP ($157.92) |
| 2021 | $310.94 | 19 | Boehringer Ingelheim Pharmaceuticals, Inc. ($101.87) |
All Payment Transactions
205 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Education | In-kind items and services | $99.26 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Respiratory | ||||||
| 12/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: RESPIRATORY | ||||||
| 11/25/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: RESPIRATORY | ||||||
| 11/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $29.28 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | United Therapeutics Corporation | REMODULIN (Drug), ORENITRAM | Food and Beverage | In-kind items and services | $29.76 | General |
| Category: Pulmonary Arterial Hypertension | ||||||
| 11/01/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: RESPIRATORY | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Respiratory | ||||||
| 10/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Immunology | ||||||
| 10/21/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/10/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $28.51 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 10/09/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $26.86 | General |
| Category: IMMUNOLOGY | ||||||
| 10/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: RESPIRATORY | ||||||
| 10/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: RESPIRATORY | ||||||
| 09/25/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $10.72 | General |
| Category: IMMUNOLOGY | ||||||
| 09/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: RESPIRATORY | ||||||
| 09/14/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $13.38 | General |
| Category: HFCWO | ||||||
| 09/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $10.91 | General |
| Category: RESPIRATORY | ||||||
| 09/05/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $25.69 | General |
| 09/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $7.98 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 604 | 865 | $136,126 | $52,020 |
| 2022 | 10 | 644 | 814 | $97,839 | $44,456 |
| 2021 | 10 | 460 | 717 | $101,499 | $41,142 |
| 2020 | 6 | 282 | 713 | $113,516 | $39,674 |
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 297 | 443 | $90,625 | $34,869 | 38.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 52 | 142 | $19,880 | $7,360 | 37.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 60 | 67 | $8,448 | $3,763 | 44.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 27 | 27 | $7,020 | $2,221 | 31.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 14 | 14 | $1,050 | $1,026 | 97.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 25 | 27 | $2,564 | $898.25 | 35.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 44 | 45 | $3,234 | $742.54 | 23.0% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 24 | 25 | $1,361 | $366.64 | 26.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 14 | 14 | $364.00 | $356.72 | 98.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 21 | $840.00 | $170.05 | 20.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 19 | 20 | $500.00 | $168.00 | 33.6% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2023 | 14 | 20 | $240.00 | $79.12 | 33.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 202 | 265 | $39,750 | $20,875 | 52.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 206 | 240 | $24,000 | $12,486 | 52.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 57 | 120 | $16,800 | $5,523 | 32.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 22 | 23 | $5,980 | $2,084 | 34.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 27 | 28 | $1,820 | $946.35 | 52.0% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 51 | 57 | $4,086 | $910.02 | 22.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 18 | 19 | $2,223 | $837.82 | 37.7% |
| 94618 | Test for exercise-induced lung stress | Office | 2022 | 28 | 28 | $2,296 | $587.38 | 25.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 16 | 17 | $680.00 | $138.16 | 20.3% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2022 | 17 | 17 | $204.00 | $68.15 | 33.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 112 | 308 | $43,120 | $14,841 | 34.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 102 | 112 | $16,800 | $9,438 | 56.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 32 | 75 | $15,750 | $5,201 | 33.0% |
About Amber Sapp, NP
Amber Sapp, NP is a Family healthcare provider based in Albany, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/18/2012. The National Provider Identifier (NPI) number assigned to this provider is 1568715340.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amber Sapp, NP has received a total of $4,048 in payments from pharmaceutical and medical device companies, with $1,788 received in 2024. These payments were reported across 205 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($3,849).
As a Medicare-enrolled provider, Sapp has provided services to 1,990 Medicare beneficiaries, totaling 3,109 services with total Medicare billing of $177,292. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Albany, GA
- Active Since 10/18/2012
- Last Updated 02/06/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1568715340
Products in Payments
- OFEV (Drug) $508.30
- DUPIXENT (Biological) $416.20
- TRELEGY ELLIPTA (Drug) $378.13
- Arikayce (Drug) $291.12
- XARELTO (Drug) $242.93
- TYVASO (Drug) $190.00
- AIRSUPRA (Drug) $169.29
- Adempas (Drug) $161.53
- ACTHAR (Biological) $155.62
- TEZSPIRE (Biological) $140.86
- BREZTRI (Drug) $101.64
- NUCALA (Biological) $90.62
- Prolastin-C Liquid (Biological) $80.32
- UPTRAVI (Drug) $78.89
- SMARTVEST (Device) $74.23
- BEVESPI AEROSPHERE (Drug) $65.64
- GLASSIA (Biological) $54.10
- AREXVY (Drug) $51.99
- REMODULIN (Drug) $50.81
- Wakix (Drug) $50.73
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Albany
Lisa Armao, Anp, ANP
Family — Payments: $61,953
Yvonne Fuller-Fontenot, F.n.p, F.N.P
Family — Payments: $48,800
Elvira Faw, Np, NP
Family — Payments: $12,359
Rodney Siau, Fnp-C, FNP-C
Family — Payments: $11,071
Mrs. Jennifer Berry, Np, NP
Family — Payments: $8,911
Melissa Stevenson
Family — Payments: $7,718